BCK Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
BCK Partners's LLY Position: Q3 2026 in Review
BCK Partners held its Eli Lilly (LLY) position steady in Q3 2026 at 200 shares worth $231K. The position accounts for 0.11% of the portfolio, ranked #26.
BCK Partners first reported a position in LLY in Q2 2024 and has held it in 6 quarters since. The position peaked at $257K in Q2 2024. 2,227 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- BCK Partners held 200 shares of Eli Lilly worth $231K as of Q3 2026.
- BCK Partners left its Eli Lilly share count unchanged in Q3 2026.
- Eli Lilly made up 0.11% of BCK Partners's portfolio in Q3 2026, its #26 holding.
- BCK Partners first reported a position in Eli Lilly in Q2 2024 and has held it in 6 quarters since.
- BCK Partners's Eli Lilly position peaked at $257K in Q2 2024.
- 2,227 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on BCK Partners's 13F filing for Q3 2026, filed 23 Oct 2026.